Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study

Fig. 3

a, b Cox regression model entering mucosal TNF gene expression normalization after last anti-TNF treatment. a Model P = 0.021; low TNF at IFX discontinuation: HR 0.36 (0.14–0.92) for long-term remission (P = 0.03). b Model P = 0.005; low TNF at IFX discontinuation: HR 0.17 (0.04–0.78) for biological free remission (P = 0.03). HR hazard ratio, IFX infliximab, TNF tumour necrosis factor

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us